abbreviatioNs CM = cavernous malformation; GRE = gradient echo; mRS = modified Rankin Scale; RICM = radiation-induced CM; RIT = radiation-induced telangiectasia; SWI = susceptibility-weighted imaging. results Thirty-two patients with RICMs were identified (56.2% men), with a median age of 31.1 years at RICM diagnosis. The median latency from radiation treatment to RICM diagnosis was 12.0 years (interquartile range 5.0-19.6 years). RICMs were always within the previous radiation port. RICMs were symptomatic at diagnosis in 46.9%, and were associated with symptomatic intracranial hemorrhage at any time in 43.8%. Older age at the time of radiation treatment and higher radiation dose were associated with shorter latency. RICMs tended to be diagnosed at a younger age than nonradiation CMs (median 31.1 vs 42.4 years, respectively; p = 0.054) but were significantly less likely to be symptomatic at the time of diagnosis (46.9% vs 65.8%, respectively; p = 0.036). RICMs were more likely to be multiple CMs than nonradiation CMs (p = 0.0002). Prospectively, the risk of symptomatic hemorrhage was 4.2% for RICMs and 2.3% for nonradiation CMs per person-year (p = 0.556). In the absence of symptoms at presentation, the risk of hemorrhage for RICMs was higher than for nonradiation CMs (4.2% vs 0.35%, respectively; p = 0.118). coNclusioNs In this patient population, RICMs occurred within the radiation port approximately 12 years after radiation treatment. Compared with nonradiation CMs, RICMs were more likely to occur as multiple CMs, to present at a younger age, and were at least as likely to cause symptomatic hemorrhage.
C avernous malformations (CMs) are well-circumscribed, multilobulated, angiographically occult vascular malformations that may be sporadic or associated with genetic mutations in CCM1, CCM2, or CCM3. In patients with a genetic predisposition, it is hypothesized that a "second hit" is required to develop CM. The nature of the second hit has been debated, with hypothesized mechanisms including infection, inflammation, additional genetic mutations, or radiation. 15 In the sporadic or acquired form, the etiology of CM is not clear, but CMs have been noted in combination with developmental venous anomalies 6, 7 and in patients with prior brain irradiation or biopsy. 29 The first explicit link between brain irradiation and de novo CM was proposed in 1992. 40 However, a 1987 report of intracerebral hemorrhage from a vascular malformation in a patient who underwent radiation treatment 8 years earlier for nasopharyngeal squamous cell carcinoma has a pathological description strikingly similar to CM, 41 and may, in fact, be the first reported case of a radiation-induced cavernous malformation (RICM). The mechanism of de novo development of an RICM in response to radia-tion therapy probably involves vascular injury, proliferation and dilation of vascular endothelium, hyalinization and fibrinoid necrosis of blood vessel walls, and finally ischemia and infarction due to narrowing of the vascular lumen. 19, 22 Evidence of this pathogenetic process includes a rat model of late radiation injury of the CNS that showed increased expression of vascular endothelial growth factor in response to radiation exposure. 37 The radiological and pathological appearances of individual RICMs are indistinguishable from sporadic or familial CMs (i.e., nonradiation CMs), but uncertainty exists as to whether these are clinically distinct entities. There are multiple reports that RICMs have a higher risk of hemorrhage than sporadic CMs, 9, 13, 22, 28, 33, 38 but the definition of hemorrhage (clinically symptomatic vs radiological only) has varied among studies, and hemorrhage risk calculations for RICMs have all been retrospective. Patient age and radiation dose may also influence the natural history of RICMs.
The natural history of RICMs remains poorly defined because these vascular lesions have been reported mostly as single case reports or in small patient series. The majority of reported cases have involved radiation treatment in childhood, with CMs discovered years or decades later. Only 8, 18, 21 in patients who received radiation therapy as adults have been previously reported, and these adult RICMs have never been compared directly with pediatric RICMs. Likewise, there has been no large-scale direct comparison of RICMs and nonradiation CMs. In this study we sought to determine the demographic factors, time from irradiation to CM diagnosis, and natural history of RICMs in comparison with nonradiation CMs, including the first calculations of prospective hemorrhage risk.
methods selection of patients with ricms
Patients were identified from the authors' (G.L., M.J.L., and K.D.F.) clinical CM databases at Mayo Clinic, a large tertiary referral center whose Institutional Review Board approved the study protocol. Patients with CMs were included if they had brain, head/neck, or chest/thorax irradiation preceding the diagnosis of intracerebral or spinal CM. Patients were excluded if radiation was given to treat a presumed CM or if surgical pathology revealed an alternative diagnosis. Age at the start of radiation treatment was used to classify cases as adult RICMs (at least 18 years of age) or pediatric RICMs (younger than 18 years of age).
Nonradiation cm patient comparison
A cohort of patients with well-defined CMs has previously been reported by the senior author (K.D.F.) and derives from a database of 292 patients with a radiological diagnosis of intracerebral CM between 1989 and 1999 at our institution. 12 Excluding those patients with a history of craniospinal irradiation from this database left 270 nonradiation CM cases.
data collection
Data were abstracted from medical records onto a standardized form and entered into a computerized database. Demographic information, personal and family medical history, initial clinical presentation, CM treatment, and functional outcome were recorded. Symptomatic hemorrhage was defined as a clinical event involving acute or subacute focal symptoms and radiological, pathological, or surgical evidence of recent extra-or intralesional hemorrhage, as previously described. 1 Data regarding radiation treatment history included age at radiation therapy, dose and port of radiation, and indication for radiation treatment. The time from radiation treatment to RICM diagnosis (latency) was calculated as the difference between age at the start of radiation treatment and age at RICM diagnosis. The age at RICM diagnosis was established either by the date of first symptoms leading to RICM visualization if symptoms were due to the RICM, or by the date of the first MRI showing the RICM if symptoms were present but not due to the RICM, or if MRI was performed only for surveillance purposes in asymptomatic patients, as for those with prior history of brain tumor. Total duration of follow-up was calculated from the age at radiation treatment to the last clinical contact.
radiological data
One of the investigators (J.K.C.G.) reviewed all brain MR images of the patients with RICMs, ranging from 1 to 29 imaging studies per patient. The imaging study closest to the time of RICM diagnosis was reviewed in detail, as was the most recent MR image. Cavernous malformations were classified as Type I, II, III, or IV, as previously described. 25, 42 The number of CMs was determined on susceptibility-weighted imaging (SWI) when available (n = 3). If SWI was not available, then gradient echo (GRE) sequences were preferred (n = 9), followed by standard T2 sequences (n = 20) if neither GRE nor SWI was available. The anterior-posterior diameter and location of symptomatic CMs were determined on standard T2 sequences. When multiple CMs were present, the location and size of symptomatic lesions were recorded. If there were multiple lesions but no symptomatic lesion, the largest lesion was used. The association of a CM with a developmental venous anomaly or other vascular malformation was also recorded when contrasted-enhanced studies were available.
statistical analysis
Descriptive statistics including means, medians, and frequencies were used for patient characteristics and presenting symptoms. Comparisons of proportions for nominal and ordinal variables were performed using the Pearson chi-square test (preferred) or 2-tailed Fisher exact test depending on sample size for the given comparison. Comparisons of proportions for continuous variables were performed with the t-test, z-test, or ANOVA. In all cases, significance was set at p < 0.05 and analyses were performed with JMP statistical software (version 10.0.0, SAS Institute Inc.). For all statistical analyses, CM location was categorized as cortical, supratentorial-subcortical, infratentorial, or spinal.
To calculate prospective hemorrhage risk, only symptomatic (clinical) hemorrhages that occurred after CM di-agnosis were counted. Person-years of prospective followup were calculated from the time of CM diagnosis to the last clinical contact, distinct from total follow-up calculated from the time of radiation therapy. For those patients whose CMs were treated, follow-up duration was censored at the time of surgical removal of the CM unless only stereotactic radiosurgery was performed, in which case there was no censoring. The annual hemorrhage rate was calculated as the number of hemorrhages during the prospective follow-up period divided by the number of person-years of follow-up. Hemorrhage risk was also stratified according to mode of initial presentation (hemorrhage vs symptoms not due to CM vs asymptomatic).
results
Thirty-two patients (18 males and 14 females) met the inclusion criteria for RICMs, with a median age of 31.1 years at RICM diagnosis (range 11.1-73.1 years). Individual patient data are shown in Table 1 . RICMs were always within the previous radiation port and were most common in the temporal cortex and brainstem. All but 1 RICM was intracerebral. The only spinal RICM occurred in the cervical cord after radiation therapy for squamous cell carcinoma of the neck. RICMs were diagnosed at a median of 12.0 years (range 0.01-60.7 years) after irradiation ( Fig.  1) . Radiation modality was external beam radiation therapy in 29 patients, stereotactic radiosurgery in 1, proton beam therapy followed by stereotactic radiosurgery in 1, and unknown in 1. RICMs were commonly multiple CMs at diagnosis, with a mean of 8.2 lesions (range 2-48 lesions) per patient when multiple. Slightly less than half of the patients with RICMs (46.9%) were symptomatic at diagnosis, and 43.8% had ever experienced a symptomatic hemorrhage. The median total follow-up duration since radiation treatment was 22.5 years (range 11.3-30.5 years), and the median prospective follow-up duration since RICM diagnosis was 4.3 years (range 1.0-10.1 years). The median radiation dose delivered in patients who developed RICM was 50 Gy (range 12-84 Gy). Surgical intervention for RICMs was pursued in 9 patients, achieving complete resection in 5 and partial resection in 4. All other RICMs were managed conservatively. No RICM was treated with stereotactic radiosurgery. Clinical features of the RICM cohort are summarized in Table 2 .
Within the RICM cohort, younger age at radiation treatment was associated with longer latency to RICM diagnosis (p = 0.015) but was not predictive of presence of symptoms, risk of hemorrhage, or RICM location. Younger age at radiation treatment was also associated with higher likelihood of multiple RICMs (p = 0.027), the only variable found to be linked to CM multiplicity. Higher radiation dose was associated with a trend toward shorter latency of RICM (p = 0.100), but again, not with presence of symptoms, risk of hemorrhage, or RICM location. RICMs in cortical locations were less likely to be symptomatic at the time of diagnosis (p = 0.049) and had a lower risk of hemorrhage (p = 0.020). Finally, there was a trend toward shorter latency to diagnosis of RICMs in infratentorial locations (p = 0.070), even though RICMs in this location were not significantly more likely to be symptomatic (p = 0.149) or to cause hemorrhage (p = 0.242).
comparison of adult and pediatric ricms
Thirteen patients underwent radiation treatment as adults, and 19 as children (Table 3) . RICM diagnosis occurred at a significantly younger age for pediatric patients with RICMs than for adult patients with RICMs (median 24.0 vs 49.4 years, p = 0.008). As in the full RICM cohort, latency to RICM diagnosis was significantly shorter for adult RICM than for pediatric RICM (p = 0.007). According to a modified Rankin Scale (mRS) score of 0 or 1, signifying no symptoms or no significant disability despite symptoms, functional outcome was more likely to be good at the time of diagnosis for pediatric RICMs compared with adult RICMs (p = 0.021). This difference in functional level did not remain statistically significant at the time of the last follow-up evaluation. Total duration of follow-up was significantly longer for pediatric RICM patients, although prospective follow-up, which was used to calculate hemorrhage risk, was not significantly different for pediatric and adult RICM patients. Otherwise, there were no significant differences between the adult and pediatric RICM groups, including similar rates of symptoms due to RICM, risk of hemorrhage, and CM multiplicity, size, and location. Adult and pediatric RICM comparisons are summarized in Table 3 .
comparison of ricms and Nonradiation cms
In comparison with a cohort not receiving radiation, those patients with RICMs tended to be diagnosed at a younger age (median 31.1 vs 42.4 years, p = 0.054) but were significantly less likely to be symptomatic at the time of diagnosis (46.9% vs 65.8%, p = 0.036). RICMs were more likely to be multiple than were nonradiation CMs (p = 0.0002). There were no significant differences in CM size, location, or MRI appearance, and similar proportions of patients with and without RICMs had good functional outcomes. Prospectively, the overall risk of hemorrhage was 4.2% per person-year for RICMs and 2.3% per person-year for nonradiation CMs, which was not a statistically significant difference (p = 0.556). For those patients with hemorrhage at presentation, the prospective risk of recurrent hemorrhage was relatively high (and not significantly different) in RICMs and nonradiation CMs (11.0% per person-year vs 5.5%, respectively; p = 0.529). For patients who were asymptomatic at the time of CM diagnosis, however, there was a trend toward higher prospective hemorrhage risk for RICMs than for nonradiation CMs (4.2% per person-year vs 0.35%, respectively; p = 0.118). RICM and nonradiation CM comparisons are summarized in Table 4 .
illustrative case case 11
In several patients with multiple follow-up MR images, an imaging pattern evolved that may be important in the pathogenesis of these lesions. For example, the patient in Case 11 underwent craniospinal irradiation at 24 years of age for germ-cell dysgerminoma of the optic chiasm. At age 31, a right parietooccipital lesion with a mixed T2 signal appeared in a previously normal region of brain ( Fig. 2A) . This lesion expanded slightly on serial imaging, acquiring the appearance of a Type II CM, but remained solitary and asymptomatic until an acute symptomatic hemorrhage at age 34 ( Fig. 2B ). This hemorrhage was managed conservatively. A GRE abnormality appeared in the left pons at age 35 ( Fig. 2C ) and then bled acutely at age 37. At the time of her second hemorrhage, a third GRE abnormality appeared in the subcortical white matter near the head of the left caudate (Fig. 2D ). This lesion has not yet bled. She has no known family history of CM and is not of Hispanic descent. Her multiple CMs are presumed to be caused by radiation therapy.
discussion
We found that RICM may occur in the brain or spinal cord, with latency to CM diagnosis inversely correlated with age at radiation treatment. A comparison of patients with RICM to those with nonradiation CM showed that RICMs were diagnosed at a younger age, were less likely to be symptomatic at the time of diagnosis, and were more likely to be multiple CMs. Importantly, the prospective risk of hemorrhage in patients with RICM was similar to that in nonradiation CM, except for those that were initially asymptomatic at presentation.
Several reports suggest that children are more susceptible than adults to the development of RICMs, 16, 19, 20, 22, 27, 33 and some authors have demonstrated an inverse relationship between radiation dose and latency to RICM diagnosis. 16, 20 Strenger and colleagues, who reported 8 RICMs in a series of 171 pediatric patients with cancer, found RICM to be more likely and have shorter latency if radiation therapy occurred in the first 10 years of life. 36 Taking together patients of all ages with RICM, our finding of a median latency of 12 years from radiation therapy to CM diagnosis is consistent with data from Keezer and Del Maestro, who gathered the majority of previously reported RICM cases (n = 84) and added 1 of their own in a 2009 report in which the mean and median latencies were 10.3 and 8 years, respectively. 20 In a stratified comparison of pediatric and adult RICM, we found that radiation treatment at a younger age makes multiple RICMs more likely. Previous series have shown multiplicity of RICMs in 41% 20 to 63% 11 of affected patients, but did not show any correlation with age at radiation treatment. In most cases, symptoms could be attributed to a single dominant lesion.
It is unclear if the significantly younger age at diagnosis of RICM by more than a decade compared with nonradiation CM reflects a mechanistic radiation effect or is due to more frequent surveillance MR images in patients previously treated with radiation. Evidence for the latter was our finding that RICMs were less likely to be symptomatic at diagnosis than were nonradiation CMs (46.9% vs 65.8%, p = 0.036), and we found that the presence or absence of symptoms had a bearing on their clinical course.
Perhaps the most concerning feature of vascular malformations, CMs and RICMs included, is their risk of hemorrhage. In this paper we report the first prospective estimate of RICM hemorrhage risk. Prospective hemorrhage rates for RICMs and nonradiation CMs were not significantly different if the manner of presentation was not taken into account. Previous work has shown that the risk of hemorrhage in nonradiation CMs is considerably higher if the CM has previously bled, especially in the first 2 years after hemorrhage. 12 Subgroup analyses comparing our patients with RICMs (n = 8) and patients with nonradiation CMs (n = 75) with hemorrhage at presentation showed similarly elevated hemorrhage risk during the prospective period. For patients asymptomatic at the time of RICM (n = 17) or nonradiation CM (n = 103) diagnosis, hemorrhage risk was nonsignificantly higher for patients with RICMs (4.2% per patient-year) compared with patients with nonradiation CMs (0.35% per patient-year, p = 0.118). Radiation-induced telangiectasias (RITs) may have a similar MRI appearance to Type IV CMs (visible on GRE or SWI only), but there are no established radiological criteria to distinguish the two. Pathologically, telangiectasia and CM differ only in the presence or absence, respectively, of intervening brain parenchyma among the dilated, thin-walled vascular channels. Because of these similarities and because transitional forms of these vascular malformations have been observed in some patients, RIT and RICM have been proposed to exist along a spectrum driven by a common proliferative pathway. 19, 22, 34 Consistent with the hypothesis that RIT precedes RICM, Gaensler and colleagues reported a series of 20 patients with RITs (6 proven pathologically) for whom the latency from irradiation to RIT development was 2.7 years (shorter than all series of RICMs) and hemorrhage risk was 25% per patient (lower than all series of RICMs). 14 Due to their radiological similarities, it is possible that some of our patients harbored RITs rather than RICMs. We believe this is unlikely, however, because all of our patients except the patient with spinal RICM (Case 8) had a largest or symptomatic lesion with appearance of Type I, II, or III CM, which are radiologically distinct from RITs. While the total number of RICMs was preferentially counted on SWI and therefore may have included RITs and overestimated the multiplicity of RICM lesions, all of the other natural history data, hemorrhage estimates, and comparisons in our study were based on the largest or symptomatic lesion that, in all but the spinal case, was radiologically an RICM and not possibly an RIT.
Of note, two patients underwent radiation treatment as children (at ages 6 and 7 years) but were not diagnosed with CM until 54 and 61 years later. The radiation dose was unknown in both cases. Even though the CM appeared within the radiation port, it is possible that these were sporadic CMs unrelated to the previous radiation therapy. We believe this is unlikely, especially because the patient with the longest latency had two CMs within the radiation port, no CM anywhere else in the brain, and no family history of CMs. Also, RICMs have previously been reported as long as 52 years after cerebral irradiation for a posterior fossa astrocytoma. 4 Finally, the statistically significant association between age at radiation treatment and latency to RICM diagnosis persisted even after these outlier patients were excluded from repeat analysis.
In several patients, a pattern of de novo appearance of RICM was observed. This pattern may provide clues to the pathogenesis of these lesions and may also represent a population in which future potential medical interventions could prove beneficial. More specifically, in Case 11, surgical removal of the symptomatic lesion would not have prevented the second hemorrhage, which arose from a separate brainstem CM that was not amenable to resection. Fasudil and simvastatin in murine models have been shown to disrupt RhoA activity in endothelial cells and may thereby stabilize CMs. In future medication trials, this group of patients with prior brain irradiation who develop a small GRE or SWI lesion may be candidates for such therapy.
Limitations of our study include the retrospective nature of the chart review and its inherent biases. In the absence of prospective screening of all patients with previous radiation treatment, symptomatic RICMs are more likely to be detected and we cannot necessarily generalize our findings to all RICMs. Tertiary referral (selection) bias may have led to more significantly symptomatic patients; in particular, patients referred from neurosurgery may overrepresent hemorrhagic RICM. Finally, due to the evolution of MRI sequences over the time frame of this study, specifically SWI, we may have underestimated the number of patients with multiple lesions.
conclusions
In this study we add 32 cases to the evolving literature on RICMs. These lesions occurred years after radiation treatment, with a longer latency and higher likelihood of multiplicity if radiation was administered at a younger age. Our prospective estimates of hemorrhage risk might inform surgical decision making in patients with CM. Initially asymptomatic RICMs have a natural history distinct from nonradiation CMs, and further study will be necessary to determine the most appropriate management steps to minimize their substantial risk of hemorrhage.
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